Rofecoxib inhibits retinal neovascularization via down regulation of cyclooxygenase‐2 and vascular endothelial growth factor expression

Publisher： John Wiley & Sons Inc

E-ISSN： 1442-9071|43|5|458-465

ISSN： 1442-6404

Source： CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol.43, Iss.5, 2015-07, pp. : 458-465

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Catechins inhibit vascular endothelial growth factor production and cyclooxygenase‐2 expression in human dental pulp cells

By  

INTERNATIONAL ENDODONTIC JOURNAL, Vol. 48, Iss. 3, 2015-03 ,pp. : 277-282

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Interaction between the Renin-Angiotensin System and Vascular Endothelial Growth Factor in the Pathogenesis of Retinal Neovascularization in Diabetes

By  

Journal of Vascular Research, Vol. 38, Iss. 6, 2001-12 ,pp. : 527-535

Karger

Access to resources Recommend Favorite

Autocrine Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor-2 Growth Pathway Represents a Cyclooxygenase-2-Independent Target for the Cyclooxygenase-2 Inhibitor NS-398 in Colon Cancer Cells

By  

Oncology, Vol. 68, Iss. 2-3, 2005-07 ,pp. : 204-211

Karger

Access to resources Recommend Favorite

Effects of lapatinib and trastuzumab on vascular endothelial growth factor in experimental corneal neovascularization

By  

CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol. 43, Iss. 5, 2015-07 ,pp. : 449-457

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic Significance of Vascular Endothelial Growth Factor and Cyclooxygenase-2 in Patients with Rectal Cancer Treated with Preoperative Radiotherapy

By  

Oncology, Vol. 71, Iss. 5-6, 2007-08 ,pp. : 312-319

Karger

Access to resources Recommend Favorite